## Abstract ## Background: Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating s
Rating scales for anxiety/anxiety disorders
β Scribed by Richard Balon
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 260 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1523-3812
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Anxiety syndromes are common in patients with Parkinson's disease (PD) with up to 30% suffering from panic disorder, and up to 11% from generalized anxiety disorder (GAD). Anxiety is associated with increased subjective motor symptoms, more severe gait problems, dyskinesias, freezing, a
Computer-administered versions of two clinician-administered symptom rating scales for social anxiety (the Liebowitz Social Anxiety Scale [LSAS] and the Brief Social Phobia Scale [BSPS]) and one paper-and-pencil scale (the Fear Questionnaire) were developed and utilized in a clinical trial for socia
Background: The Multidimensional Anxiety Scale for Children (MASC) is a widely used self-report questionnaire for the assessment of anxiety symptoms in children and adolescents. Methods: This study used receiver operating characteristic analyses to investigate the predictive value of the MASC total
## Abstract Tiagabine, a selective gammaβaminobutyric acid (GABA) reuptake inhibitor was evaluated for the treatment of patients with social anxiety disorder (SAD). Adults with SAD received openβlabel tiagabine 4β16βmg per day for 12 weeks. Intentβtoβtreat data are available for 54 patients with im